Dana Deane, CNM | |
2051 John Jones Rd, Davis, CA 95616-9701 | |
(530) 753-3498 | |
(530) 758-3109 |
Full Name | Dana Deane |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 2051 John Jones Rd, Davis, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093189466 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
Entity Name | Dhp Of California Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679836084 PECOS PAC ID: 9234388745 Enrollment ID: O20120927000044 |
News Archive
Pall Corporation, a global leader in filtration, separation and purification, today introduced a new filtration process that significantly improves the safety and quality of infant formula. The Pall process is engineered to prevent microbial contamination through intensive filtration, while preserving nutritional quality by minimizing the need for repeated heat treatment during manufacturing.
Hanli Liu, a professor of bioengineering at The University of Texas at Arlington, is working to improve memory and cognitive function in astronauts during space missions by directing light onto their brains.
"The treatment of breast cancer when the patient is pregnant does not increase the risk of congenital anomalies", assures Dr. Guillermo López, director of the Department of Gynaecology and Obstetrics at the University Hospital of the University of Navarra.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).
› Verified 9 days ago
Entity Name | Communicare Health Centers |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558366823 PECOS PAC ID: 0345299186 Enrollment ID: O20161129002365 |
News Archive
Pall Corporation, a global leader in filtration, separation and purification, today introduced a new filtration process that significantly improves the safety and quality of infant formula. The Pall process is engineered to prevent microbial contamination through intensive filtration, while preserving nutritional quality by minimizing the need for repeated heat treatment during manufacturing.
Hanli Liu, a professor of bioengineering at The University of Texas at Arlington, is working to improve memory and cognitive function in astronauts during space missions by directing light onto their brains.
"The treatment of breast cancer when the patient is pregnant does not increase the risk of congenital anomalies", assures Dr. Guillermo López, director of the Department of Gynaecology and Obstetrics at the University Hospital of the University of Navarra.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dana Deane, CNM Po Box 1260, Davis, CA 95617-1260 Ph: (530) 753-3498 | Dana Deane, CNM 2051 John Jones Rd, Davis, CA 95616-9701 Ph: (530) 753-3498 |
News Archive
Pall Corporation, a global leader in filtration, separation and purification, today introduced a new filtration process that significantly improves the safety and quality of infant formula. The Pall process is engineered to prevent microbial contamination through intensive filtration, while preserving nutritional quality by minimizing the need for repeated heat treatment during manufacturing.
Hanli Liu, a professor of bioengineering at The University of Texas at Arlington, is working to improve memory and cognitive function in astronauts during space missions by directing light onto their brains.
"The treatment of breast cancer when the patient is pregnant does not increase the risk of congenital anomalies", assures Dr. Guillermo López, director of the Department of Gynaecology and Obstetrics at the University Hospital of the University of Navarra.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).
› Verified 9 days ago
Gloria Aimee Gonzalez, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2051 John Jones Rd, Davis, CA 95616 Phone: 530-758-2060 Fax: 530-758-8490 | |
Ms. Isabella C Blackman, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2051 John Jones Rd, Davis, CA 95616 Phone: 530-753-3498 | |
Jessica Lynn Witty Nagel, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2020 Sutter Pl, Suite 203, Davis, CA 95616 Phone: 530-750-5880 Fax: 530-750-5881 | |
Jennifer Millspaugh Taylor, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2051 John Jones Rd, Davis, CA 95616 Phone: 530-758-1510 | |
Elizabeth Morales, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2051 John Jones Rd, Davis, CA 95616 Phone: 530-758-2060 | |
Barbara Jean Boehler, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2040 Sutter Pl, Davis, CA 95616 Phone: 530-758-2060 |